Sanuwave Health (SNWV) Stock Price, News & Analysis

Company Overview

SANUWAVE Health, Inc. is a medical technology company focused on regenerative medicine and the development of noninvasive treatments for wound healing and tissue repair. Its technology uses acoustic shock waves to stimulate biological responses that may support blood-vessel growth, tissue regeneration and healing.

The company’s principal product is the dermaPACE System, an extracorporeal shock wave therapy device designed for use in treating chronic wounds, including diabetic foot ulcers. SANUWAVE has also pursued applications of its technology in other wound-care and tissue-repair areas, such as pressure ulcers, venous ulcers, burns and certain musculoskeletal conditions.

SANUWAVE has historically sought to commercialize its products in the United States and international markets, including regions where applicable regulatory clearances and distribution arrangements are available. The company’s activities have centered on clinical development, regulatory approvals and commercialization of its regenerative medicine platform.

Key Stats

• Today's Range: $5.47 to $5.90
• 50-Day Range: $4.00 to $6.00
• 52-Week Range: $3.92 to $36.42
• Volume: 32,001 shs
• Average Volume: 61,933 shs
• Market Capitalization: $48.25 million
• P/E Ratio: 24.33
• Dividend Yield: N/A
• Price Target: $47.00
• Consensus Rating: Reduce

Sanuwave Health Stock Analysis - MarketRank™

Sanuwave Health scored higher than 48% of companies evaluated by MarketBeat, and ranked 580th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Reduce

Consensus Rating

Sanuwave Health has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 2 sell ratings.

Upside Potential

Sanuwave Health has a consensus price target of $47.00, representing about 737.8% upside from its current price of $5.61.

Amount of Analyst Coverage

Sanuwave Health has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Sanuwave Health is 24.33, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 35.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sanuwave Health is 24.33, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 198.59.

Price to Book Value per Share Ratio

Sanuwave Health has a P/B Ratio of 29.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.33% of the float of Sanuwave Health has been sold short.

Short Interest Ratio / Days to Cover

Sanuwave Health has a short interest ratio ("days to cover") of 3.91, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sanuwave Health has recently increased by 2.16%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Sanuwave Health does not currently pay a dividend.

Dividend Growth

Sanuwave Health does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.60

News Sentiment

Sanuwave Health has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Sanuwave Health this week, compared to 1 article on an average week.

Company Ownership

• Score: 1.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sanuwave Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

14.40% of the stock of Sanuwave Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

42.53% of the stock of Sanuwave Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 10/13/2026
• Next Earnings (Estimated): 11/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:SNWV
• Previous Symbol: NASDAQ:SNWV
• CIK: 1417663
• Web: sanuwave.com
• Phone: (952) 656-1029
• Fax: 770-419-8634
• Employees: 55
• Year Founded: 2005

Price Target and Rating

• Average Price Target for Sanuwave Health: $47.00
• High Price Target: $47.00
• Low Price Target: $47.00
• Potential Upside/Downside: +737.8%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.24
• Trailing P/E Ratio: 24.33
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $11.81 million
• Net Margins: 32.38%
• Pretax Margin: 34.73%
• Return on Equity: 1,728.10%
• Return on Assets: 39.04%

Debt

• Debt-to-Equity Ratio: 4.87
• Current Ratio: 1.28
• Quick Ratio: 0.89

Sales & Book Value

• Annual Sales: $44.05 million
• Price / Sales: 1.10
• Cash Flow: $1.63 per share
• Price / Cash Flow: 3.44
• Book Value: $0.19 per share
• Price / Book: 29.53

Miscellaneous

• Outstanding Shares: 8,600,000
• Free Float: 7,363,000
• Market Cap: $48.25 million
• Optionable: N/A
• Beta: 1.42